ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 13.9 | 8.8 | 8.8 |
| Other income | 0.2 | 0.1 | 1.0 |
| Total income | 14.2 | 8.9 | 9.8 |
| Profit before exceptional items & tax | 1.9 | 1.1 | 1.7 |
| Profit before tax | 1.9 | 1.1 | 1.7 |
| Net profit | 1.2 | 1.0 | 0.7 |
| Operating margin | 13.4% | 12.4% | 17.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +71.40% |
|---|---|
| Net profit, quarter on quarter | +20.00% |
| Revenue, year on year | +58.00% |
| Operating profit, year on year | +142.90% |
| Operating profit, quarter on quarter | +70.00% |
BSE results filing, NSE: AUROLAB. Figures extracted from the filing.
Auro Laboratories Ltd: key numbers
- Share price
- ₹234.50
- Market cap
- ₹146.2 Cr
- Revenue (annual)
- ₹32.61 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 31.2×Sector 43.8×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Auro Laboratories Ltd
All →Auro Laboratories Board Meeting Date
Auro Laboratories scheduled a November 13, 2026 board meeting to approve unaudited September quarter results. The trading window stays closed until 48 hours after the meeting.
Auro Laboratories Other Announcement
Auro Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Auro Laboratories Q1 FY27 Results: Turns Profitable, Net Profit ₹1 Cr
Auro Laboratories Ltd reported revenue from operations of ₹8.8 Cr (+214.3% YoY) and net profit of ₹1 Cr for Q1 FY27.
- Key figure
- Net profit ₹1 Cr
Auro Laboratories Annual General Meeting
Auro Laboratories Limited held its 37th Annual General Meeting on August 11, 2026, via video conferencing. The company conducted all items of business as listed in the notice.
Auro Laboratories Board Meeting Date
Auro Laboratories Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Auro Laboratories Other Announcement
Auro Laboratories issued a notice to shareholders regarding its 37th AGM scheduled for August 11, 2026. The letter provides web-links to access the FY 2025-26 Annual Report.